The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer

Conclusion: The BRAF V600E mutation is closely related to serum Tg elevation after treatment with iodine-131 in papillary thyroid cancer. These findings suggest that this BRAF mutation may be a predictor of the efficacy of iodine-131 treatment for papillary thyroid cancer.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Junshang Ge, Jie Wang, Hui Wang, Xianjie Jiang, Qianjin Liao, Qian Gong, Yongzhen Mo, Xiaoling Li, Guiyuan Li, Wei Xiong, Jin Zhao, Zhaoyang Zeng Tags: Research Paper Source Type: research